Steven Paul Hanlon

Title: The Innovations of Steven Paul Hanlon

Introduction

Steven Paul Hanlon is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the development of mutant transaminases and pharmaceutical compounds. With a total of 5 patents, Hanlon's work has had a considerable impact on both scientific research and practical applications.

Latest Patents

Among his latest patents, Hanlon has developed a mutant transaminase with increased activity compared to the wild-type transaminase. This invention includes a fusion protein comprising the transaminase, a polynucleotide coding for the transaminase, and a host cell containing the polynucleotide. Additionally, he has created a method for producing amines using the mutant transaminase or fusion protein. Another significant patent involves a process for preparing isoxazolyl-methoxy nicotinic acids, which serve as intermediates in the synthesis of active pharmaceutical compounds.

Career Highlights

Throughout his career, Hanlon has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Hanlon has collaborated with esteemed colleagues such as Hans Iding and Paul Spurr. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Steven Paul Hanlon's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in pharmaceutical research and development.